• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体递送系统的制备及其对雷帕霉素的释放

Preparation of a liposomal delivery system and its release of rapamycin.

作者信息

Miao Zhi-Lin, Deng Ying-Jie, DU Hong-Yang, Suo Xu-Bin, Wang Xiao-Yu, Wang Xiao, Wang Li, Cui Li-Jie, Duan Na

机构信息

Heart Center, The People's Hospital of Liaoning Province, Shenyang, Liaoning 110016, P.R. China.

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, P.R. China.

出版信息

Exp Ther Med. 2015 Mar;9(3):941-946. doi: 10.3892/etm.2015.2201. Epub 2015 Jan 22.

DOI:10.3892/etm.2015.2201
PMID:25667657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4316897/
Abstract

The aim of this study was to prepare a liposomal delivery system for rapamycin and study its release characteristics. The results may provide a foundation for the further development of a liposomal delivery system for rapamycin and the establishment of a new active treatment method targeted towards the cellular components of atherosclerotic plaques. The ethanol injection method was used to prepare rapamycin-containing liposomes. The formulation was optimized by orthogonal design, and the degree of rapamycin release by the liposomes was measured by the reverse dialysis method. Orthogonal testing showed that the optimum formulation had a phospholipid concentration of 4%, a phospholipid-cholesterol mass ratio of 8:1, a drug-lipid mass ratio of 1:20 and an aqueous phase pH of 7.4. Rapamycin-containing liposomes with an encapsulation efficiency of 82.11±2.13% were prepared, and the release of rapamycin from the liposomes complied with a first-order kinetic equation. In conclusion, the formulation was optimized, the prepared liposomes had a high rapamycin encapsulation rate and good reproducibility, and their release had a certain delayed-release effect.

摘要

本研究的目的是制备雷帕霉素脂质体递送系统并研究其释放特性。研究结果可为雷帕霉素脂质体递送系统的进一步开发以及建立针对动脉粥样硬化斑块细胞成分的新型活性治疗方法奠定基础。采用乙醇注入法制备含雷帕霉素脂质体。通过正交设计对制剂进行优化,并用反向透析法测定脂质体对雷帕霉素的释放度。正交试验表明,最佳制剂的磷脂浓度为4%,磷脂与胆固醇质量比为8:1,药物与脂质质量比为1:20,水相pH值为7.4。制备了包封率为82.11±2.13%的含雷帕霉素脂质体,雷帕霉素从脂质体中的释放符合一级动力学方程。综上所述,优化了制剂,所制备的脂质体雷帕霉素包封率高、重现性好,其释放具有一定的缓释效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/41ec3478e8f7/ETM-09-03-0941-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/d443a301a37f/ETM-09-03-0941-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/a96f160b27e6/ETM-09-03-0941-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/41ec3478e8f7/ETM-09-03-0941-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/d443a301a37f/ETM-09-03-0941-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/a96f160b27e6/ETM-09-03-0941-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019e/4316897/41ec3478e8f7/ETM-09-03-0941-g02.jpg

相似文献

1
Preparation of a liposomal delivery system and its release of rapamycin.脂质体递送系统的制备及其对雷帕霉素的释放
Exp Ther Med. 2015 Mar;9(3):941-946. doi: 10.3892/etm.2015.2201. Epub 2015 Jan 22.
2
Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate.甘草次酸硬脂酯修饰去甲斑蝥素脂质体的制备与表征
Exp Ther Med. 2018 Sep;16(3):1639-1646. doi: 10.3892/etm.2018.6416. Epub 2018 Jul 6.
3
A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.一种用于康普瑞汀A4的靶向脂质体递送系统:通过载药和体外释放研究进行制剂优化
PDA J Pharm Sci Technol. 2006 May-Jun;60(3):144-55.
4
[Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro].顺铂多囊泡脂质体的制备及顺铂在体外从脂质体中的释放
Yao Xue Xue Bao. 2003 Feb;38(2):133-7.
5
Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.新型流场流分离药物释放/传递分析法研究脂质体载体中难溶性药物的损失机制和动力学。
J Control Release. 2016 Jun 28;232:228-37. doi: 10.1016/j.jconrel.2016.04.031. Epub 2016 Apr 23.
6
Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.通过乙醇注入法制备的含新型喜树碱类似物(吉马替康)的脂质体。
J Liposome Res. 2004;14(1-2):87-109. doi: 10.1081/lpr-120039794.
7
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.局部脂质体中的他莫昔芬:研发、表征及体外评价
J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.
8
Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.用于雷帕霉素的促融合pH敏感脂质体制剂:抗增殖效果的改善
Pharm Biol. 2014 Jul;52(7):848-54. doi: 10.3109/13880209.2013.871640. Epub 2014 Feb 7.
9
Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation.优化加替沙星脂质体水凝胶以增强透角膜渗透。
J Liposome Res. 2010 Mar;20(1):31-7. doi: 10.3109/08982100903030255.
10
Formulation and advantages of furazolidone in liposomal drug delivery systems.呋喃唑酮在脂质体药物递送系统中的制剂及优势
Eur J Pharm Sci. 2016 Mar 10;84:139-45. doi: 10.1016/j.ejps.2016.01.017. Epub 2016 Jan 18.

引用本文的文献

1
5-Fluorouracil- and Sesamol-Loaded Transliposomal Gel for Skin Cancer: , and Dermatokinetic Evaluation.用于皮肤癌的载有5-氟尿嘧啶和芝麻酚的转脂质体凝胶:……及皮肤动力学评估。 (注:原文中“,”处内容缺失)
ACS Omega. 2025 Feb 12;10(7):6857-6875. doi: 10.1021/acsomega.4c09147. eCollection 2025 Feb 25.
2
Physical Properties of Cellulose Derivative-Based Edible Films Elaborated with Liposomes Encapsulating Grape Seed Tannins.基于纤维素衍生物的可食用薄膜的物理性质,该薄膜由包封葡萄籽单宁的脂质体制备而成。
Antioxidants (Basel). 2024 Aug 14;13(8):989. doi: 10.3390/antiox13080989.
3
Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation.

本文引用的文献

1
Surface engineering of liposomes for stealth behavior.脂质体的表面工程实现隐形行为。
Pharmaceutics. 2013 Oct 25;5(4):542-69. doi: 10.3390/pharmaceutics5040542.
2
Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges.纳米颗粒药物递送系统的溶出度测试策略:最新进展与挑战
Drug Deliv Transl Res. 2013 Oct 1;3(5):409-415. doi: 10.1007/s13346-013-0129-z.
3
Synthesis of VIP-lipopeptide using a new linker to modify liposomes: towards the development of a drug delivery system for active targeting.
西罗莫司纳米原位凝胶眼用制剂的制备及体内和体外研究
J Nanobiotechnology. 2024 Jul 16;22(1):417. doi: 10.1186/s12951-024-02668-1.
4
Guidelines for the role of autophagy in drug delivery vectors uptake pathways.自噬在药物递送载体摄取途径中的作用指南。
Heliyon. 2024 Apr 24;10(9):e30238. doi: 10.1016/j.heliyon.2024.e30238. eCollection 2024 May 15.
5
Silica nanocarrier-mediated intracellular delivery of rapamycin promotes autophagy-mediated M2 macrophage polarization to regulate bone regeneration.二氧化硅纳米载体介导的雷帕霉素细胞内递送促进自噬介导的M2巨噬细胞极化以调节骨再生。
Mater Today Bio. 2023 Mar 31;20:100623. doi: 10.1016/j.mtbio.2023.100623. eCollection 2023 Jun.
6
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery.用于药物、基因和疫苗递送的鼻内脂质体的最新进展
Pharmaceutics. 2023 Jan 6;15(1):207. doi: 10.3390/pharmaceutics15010207.
7
Transferrin-Functionalized Liposomes for the Delivery of Gallic Acid: A Therapeutic Approach for Alzheimer's Disease.用于递送没食子酸的转铁蛋白功能化脂质体:一种治疗阿尔茨海默病的方法。
Pharmaceutics. 2022 Oct 11;14(10):2163. doi: 10.3390/pharmaceutics14102163.
8
Sialyl LewisX mimic-decorated liposomes for anti-angiogenic everolimus delivery to E-selectin expressing endothelial cells.用于将抗血管生成依维莫司递送至表达E-选择素的内皮细胞的唾液酸LewisX模拟物修饰的脂质体。
RSC Adv. 2019 Jul 2;9(36):20518-20527. doi: 10.1039/c9ra01943j. eCollection 2019 Jul 1.
9
Cholesterol Levels Affect the Performance of AuNPs-Decorated Thermo-Sensitive Liposomes as Nanocarriers for Controlled Doxorubicin Delivery.胆固醇水平影响金纳米颗粒修饰的热敏脂质体作为阿霉素控释纳米载体的性能。
Pharmaceutics. 2021 Jun 27;13(7):973. doi: 10.3390/pharmaceutics13070973.
10
Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis.靶向治疗策略联合纳米医学递药在动脉粥样硬化中的应用。
Acta Pharmacol Sin. 2021 Jan;42(1):10-17. doi: 10.1038/s41401-020-0436-0. Epub 2020 May 26.
使用新型连接体修饰脂质体合成血管活性肠肽-脂肽:迈向主动靶向药物递送系统的发展
Chem Pharm Bull (Tokyo). 2013;61(11):1184-7. doi: 10.1248/cpb.c13-00518. Epub 2013 Aug 23.
4
Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.基于靶向肾脏给药的新型霉酚酸-氨基葡萄糖缀合物的研究进展
Int J Pharm. 2013 Nov 1;456(1):223-34. doi: 10.1016/j.ijpharm.2013.07.064. Epub 2013 Aug 21.
5
Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.基于纳米技术的药物传递系统用于靶向、成像和诊断神经退行性疾病。
Pharm Res. 2013 Oct;30(10):2499-511. doi: 10.1007/s11095-013-1156-7.
6
Liposomes in drug delivery: a patent review (2007 - present).脂质体在药物传递中的应用:专利审查(2007 年至今)。
Expert Opin Ther Pat. 2013 Nov;23(11):1399-414. doi: 10.1517/13543776.2013.828035. Epub 2013 Aug 19.
7
Immunoliposomes.免疫脂质体。
Curr Med Chem. 2012;19(31):5239-77. doi: 10.2174/092986712803833362.
8
Use of partial AUC to demonstrate bioequivalence of Zolpidem Tartrate Extended Release formulations.使用部分 AUC 来证明酒石酸唑吡坦延长释放制剂的生物等效性。
Pharm Res. 2012 Apr;29(4):1110-20. doi: 10.1007/s11095-011-0662-8. Epub 2012 Jan 26.
9
Vaccination strategies in atherosclerosis.动脉粥样硬化的疫苗接种策略。
Thromb Haemost. 2011 Nov;106(5):796-803. doi: 10.1160/TH11-05-0369. Epub 2011 Oct 20.
10
Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.通过纳米载体介导的亚细胞靶向提高药物效力和疗效。
Sci Transl Med. 2011 Jan 5;3(64):64ra2. doi: 10.1126/scitranslmed.3001385.